Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Falciparum malaria: current therapeutic challenges.

Kathryn Maitland1, Michael Makanga, Thomas N Williams

  • 1The Centre for Geographic Medicine Research, Coast, KEMRI, Kilifi, Kenya. Kmaitland@kilifi.mimcom.net

Current Opinion in Infectious Diseases
|September 9, 2004
PubMed
Summary

Antimalarial drug resistance is rising, threatening malaria treatment. Newer drugs offer hope, but cost and political will are barriers to widespread use, especially for severe childhood malaria.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe anaemia and invasive bacterial infections in Kenyan children: a 26-year hospital surveillance observational study.

The Lancet. Global health·2026
Same author

Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda.

The New England journal of medicine·2026
Same author

Cumulative <i>Plasmodium falciparum</i> infections do not drive long-term telomere shortening in Kenyan children.

Frontiers in cellular and infection microbiology·2026
Same author

Intravenous rehydration in children with severe malnutrition and severe dehydration: a systematic review and meta-analysis.

Archives of disease in childhood·2026
Same author

Synthesis and Standardization of Outcomes in Severe Malaria Treatment Trials: Protocol for the Development of a Core Outcome Set (the COSSMaT Study).

JMIR research protocols·2026
Same author

Growth and puberty in African children with sickle cell anemia treated with hydroxyurea.

Blood advances·2026

Area of Science:

  • Global Health
  • Infectious Diseases
  • Pharmacology

Background:

  • Malaria remains a significant global health burden, particularly in developing nations.
  • Increasing antimalarial drug resistance compromises existing treatment strategies.
  • High mortality rates persist among children with severe malaria.

Purpose of the Study:

  • To review current trends in antimalarial drug resistance.
  • To assess the progress of novel antimalarial drugs and combinations.
  • To examine recent literature on severe malaria pathogenesis for improved pediatric management.

Main Methods:

  • Literature review of antimalarial drug resistance.
  • Analysis of newer drug and combination therapy development.
  • Review of pathological processes in severe malaria.

Related Experiment Videos

Main Results:

  • Resistance to first-line therapies (e.g., chloroquine) is increasing globally.
  • Financial and political factors impede the availability of effective new drugs.
  • Promising new drugs and supportive treatments for malaria are in development.

Conclusions:

  • Newer antimalarial drugs and fixed-dose combinations are safe and effective but costly.
  • Widespread implementation requires substantial political and financial commitment.
  • Further research into severe malaria pathogenesis is crucial for developing universally applicable therapies.